Emisphere Tech (EMIS) 0.6900 $EMIS Emisphere Reports

New Post Public Reply Private Reply Replies (0) Message Board

Aug 20, 2016 at 9:03 AM

Emisphere Tech (EMIS) 0.6900 $EMIS

Emisphere Reports Second Quarter 2016 Financial Results
GlobeNewswire - Mon Aug 15, 6:30AM CDT
Emisphere Technologies, Inc. (OTCBB:EMIS) today reported financial results for the second quarter ended June 30, 2016, and provided an overview of corporate accomplishments and plans.
NVO: 46.88 (-0.16)

Emisphere Announces Second Quarter 2016 Earnings Conference Call
GlobeNewswire - Mon Aug 08, 3:05PM CDT
Emisphere Technologies, Inc. (OTCBB:EMIS) announced today that management will host a conference call to discuss the Company's financial and operational results for the three months ended June 30, 2016, on Monday, August 15, 2016, at 8:30 AM ET. A press release will be issued prior to market open.

CutisPharma Appoints Steven Dinh As Chief Scientific Officer
PR Newswire - Mon Aug 01, 5:00AM CDT
CutisPharma today announced the appointment of Steven Dinh, Sc.D., as Executive Vice President and Chief Scientific Officer. In this key role, Dinh will oversee the Company's efforts to develop its pipeline of drugs for New Drug Application (NDA) submission to the U.S. Food and Drug Administration.
NVS: 81.34 (-0.60)

Emisphere Announces First Quarter 2016 Earnings Conference Call
GlobeNewswire - Mon May 09, 3:30PM CDT
Emisphere (OTCQB:EMIS) announced today that management will host a conference call to discuss the Company's financial and operational results for the three months ended March 31, 2016, on Monday, May 16, 2016, at 8:30 AM ET. A press release will be issued prior to market open.

Emisphere Reports Fourth Quarter and Full Year 2015 Financial Results
GlobeNewswire - Tue Mar 29, 7:08AM CDT
Emisphere Technologies, Inc. (OTCBB:EMIS) today reported financial results for the fourth quarter and full fiscal year ended December 31, 2015, and provided an overview of corporate accomplishments and plans.
NVO: 46.88 (-0.16)

Emisphere Announces 2015 Earnings Conference Call
GlobeNewswire - Thu Mar 24, 7:00AM CDT
Emisphere (OTCQB:EMIS) announced today that management will host a conference call to discuss the Company's financial and operational results for the twelve months ended December 31, 2015, on Tuesday, March 29, 2016, at 8:30 AM ET. A press release will be issued prior to market open.

Emisphere Reports Third Quarter 2015 Financial Results
GlobeNewswire - Mon Nov 16, 6:55AM CST
Emisphere Technologies, Inc. (OTCBB:EMIS) today reported financial results for the third quarter ended September 30, 2015, and provided a corporate update.
NVO: 46.88 (-0.16)

Emisphere Announces Third Quarter 2015 Financial Results Conference Call
GlobeNewswire - Tue Nov 10, 3:35PM CST
Emisphere Technologies, Inc. (OTCBB:EMIS) announced today that Management will host a conference call on Monday, November 16, 2015, at 8:30 AM ET to discuss the Company's financial and operational results for the third quarter ended September 30, 2015.

Emisphere to Present at SeeThruEquity MicroCap Investor Forum
GlobeNewswire - Thu Nov 05, 3:15PM CST
Emisphere Technologies, Inc. (OTCBB:EMIS) today announced that President and Chief Executive Officer, Alan L. Rubino, will present at the SeeThruEquity MicroCap Investor Forum at 9:30 AM ET on Thursday, November 12, 2015. The SeeThruEquity conference is being held at the Convene Grand Central in New York City.

Emisphere Signs License Agreement With Novo Nordisk to Develop Oral Formulations of Four Molecules Targeting Metabolic Indications and Amends GLP-1 Agreement
GlobeNewswire - Thu Oct 15, 7:20AM CDT
Emisphere Technologies, Inc. today announced that it has entered into a Development and License Agreement with Novo Nordisk A/S (NYSE:NVO) to develop and commercialize oral formulations of four classes of Novo Nordisk's investigational molecules targeting major metabolic disorders, including diabetes and obesity, using Emisphere's oral Eligen(R) Technology. Under the terms of the agreement, Emisphere licensed to Novo Nordisk the exclusive right to develop potential product candidates in three molecule classes, and the non-exclusive right to develop potential product candidates in a fourth molecule class, using the Eligen(R) Technology.
NVO: 46.88 (-0.16)

Emisphere to Present at Rodman and Renshaw 17th Annual Global Investment Conference
GlobeNewswire - Wed Sep 02, 3:15PM CDT
Emisphere Technologies, Inc. (OTCBB:EMIS) today announced that President and Chief Executive Officer, Alan L. Rubino, will present at the Rodman and Renshaw 17 Annual Global Investment Conference at 9:35 AM ET on Wednesday, September 9, 2015. The Rodman and Renshaw conference is being held at The St. Regis Hotel in New York City.

Novo Nordisk to Start PIONEER Program on Semaglutide
Zacks Equity Research - Zacks Investment Research - Thu Aug 27, 2:30PM CDT
Novo Nordisk (NVO) announced that it intends to start the phase IIIa PIONEER program on once-daily oral semaglutide for the treatment of type II diabetes.
NVO: 46.88 (-0.16), MRK: 63.36 (-0.27), LLY: 79.06 (-0.72)

Emisphere Announces Second Quarter 2015 Financial Results Conference Call
GlobeNewswire - Thu Aug 06, 3:30PM CDT
Emisphere Technologies, Inc. (OTCQB:EMIS) announced today that Management will host a conference call on Wednesday, August 12, 2015, at 8:30 AM ET to discuss the Company's financial and operational results for the second quarter ended June 30, 2015.

Emisphere Reports First Quarter 2015 Financial Results
GlobeNewswire - Fri May 15, 7:00AM CDT
Emisphere Technologies, Inc. (OTCBB:EMIS) today reported financial results for the first quarter ended March 31, 2015, and provided an overview of corporate accomplishments and plans.

Emisphere Announces First Quarter 2015 Financial Results Conference Call
GlobeNewswire - Mon May 11, 3:15PM CDT
Emisphere Technologies, Inc. (OTCQB:EMIS) announced today that management will host a conference call on Friday, May 15, 2015, at 8:30 AM EDT to discuss the Company's financial and operational results for the quarter ended March 31, 2015.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Salveo Home Care Faces Class Action Over Labor Violations

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Quay Shines in 2026 Prescription Sunglasses Lineup

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Revamping Children's Radiotherapy: Leo Cancer Care's Vision

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Leo Cancer Care's Upright Radiotherapy Milestone

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Accuray, Samsung Push Boundaries with Imaging Deal

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

AI Memory Growth Pushes Limits at GMIF2026 Summit

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

IASO's FUCASO Shows Robust Results in 2026 Study

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

DKS Facing Class Action Over Stock Slump Allegations

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...